Compare ARAY & EML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARAY | EML |
|---|---|---|
| Founded | 1990 | 1858 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.5M | 119.2M |
| IPO Year | 2007 | N/A |
| Metric | ARAY | EML |
|---|---|---|
| Price | $0.84 | $18.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 826.4K | 15.0K |
| Earning Date | 02-04-2026 | 03-10-2026 |
| Dividend Yield | N/A | ★ 2.42% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.19 |
| Revenue | ★ $450,902,000.00 | $258,121,226.00 |
| Revenue This Year | $3.82 | $1.56 |
| Revenue Next Year | $4.08 | $7.00 |
| P/E Ratio | ★ N/A | $17.61 |
| Revenue Growth | ★ 1.51 | N/A |
| 52 Week Low | $0.78 | $18.01 |
| 52 Week High | $2.95 | $29.55 |
| Indicator | ARAY | EML |
|---|---|---|
| Relative Strength Index (RSI) | 40.04 | 45.36 |
| Support Level | $0.79 | $18.01 |
| Resistance Level | $0.88 | $19.04 |
| Average True Range (ATR) | 0.05 | 0.57 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 32.90 | 16.39 |
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.